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Abstract.  During development of the rat central ner- 
vous system, neural cell adhesion molecule (NCAM) 
mRNAs containing  in the extracellular domain a  30-bp 
alternative exon, here named VASE, replace RNAs 
that lack this exon.  The presence of this alternative 
exon between previously described exons 7 and 8 
changes the predicted loop structure of the derived 
polypeptide from one resembling an immunoglobulin 
constant region domain to one resembling an immuno- 
globulin variable domain.  This change could have 
significant effects on NCAM polypeptide function and 
cell-cell interaction.  In this report we test multiple rat 
tissues for the presence of additional alternative exons 
at this position and also examine the regulation of 
splicing of the previously described exon.  To sensi- 
tively examine alternative  splicing,  polymerase chain 
reactions (PCRs) with primers flanking the exon 
7/exon 8 alternative splicing site were performed.  Four 
categories of RNA samples were tested for new exons: 
whole brain from embryonic day  11 to adult,  specific 
brain regions dissected from adult brain,  clonal lines 
of neural cells in vitro, and muscle cells and tissues 
cultured in vitro and obtained by dissection.  Within 
the limits of the PCR methodology, no evidence for 
any alternative exon other than the previously 
identified VASE was obtained.  The regulation of ex- 
pression of this exon was found to be complex and tis- 
sue specific. Expression of the 30-bp exon in the heart 
and nervous system was found to be regulated in- 
dependently; a  significant proportion of embryonic day 
15 heart NCAM mRNAs contain VASE while only a 
very small amount of day  15 nervous system mRNAs 
contain VASE.  Some adult central nervous system 
regions,  notably the olfactory bulb and the peripheral 
nervous system structures adrenal gland and dorsal 
root ganglia,  express NCAM which contains very little 
VASE.  VASE is undetectable in NCAM PCR products 
from the olfactory epithelium.  Other nervous system 
regions express significant quantities of NCAM both 
with and without VASE.  Clonal cell lines in culture 
generally expressed very little VASE.  These results in- 
dicate that a  single alternative exon, VASE,  is found in 
NCAM immunoglobulin-like loop 4 and that distinct 
tissues and nervous system regions regulate expression 
of VASE independently both during development and 
in adult animals. 
T 
HE primary strategy for developmental regulation  of 
the expression of most individual  gene products is at 
the level of  abundance.  Most genes give rise to a single 
polypeptide product whose abundance is controlled through 
mechanisms  regulating  transcriptional  and  translational 
events and polypeptide turnover. The evolution of multigene 
families has allowed a second strategy for regulation of gene 
expression:  selective expression  of single  members of the 
family in different tissues or distinct  times in development. 
A third  strategy for selective polypeptide expression is via 
While this manuscript was under review we learned of an additional alterna- 
tively spliced exon between exons 7 and 8 of rat NCAM which is present 
at '~3 % the abundance of the VASE exon (Barbara Bowen and Walter Gil- 
bert, personal communication). This abundance is similar to that estimated 
above for the maximum abundance of any exons in additions to VASE. 
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alternative splicing. In genes that generate multiple polypep- 
tide products through  alternative  splicing,  both the relative 
abundance and the precise splicing patterns of all gene prod- 
ucts must be regulated.  A large and rapidly increasing  num- 
ber of genes are known to be alternatively  spliced (Breitbart 
et al.,  1987). While some genes have splicing patterns that 
are apparently  stochastic,  others are clearly regulated in tis- 
sue-specific  or developmental  patterns. 
Neural cell adhesion  molecule (NCAM) ~ is a  group of 
cell  surface  glycoproteins  derived  from  a  single  gene. 
NCAMs are found in high levels in neural tissues in adult 
animals  and are expressed more widely during  early devel- 
opment (Edelman,  1988;  Lirmeman  and Bock,  1989).  A 
number of studies have demonstrated the role of NCAM in 
cell-cell adhesion  including  the interaction  of cells of the 
1. Abbreviations used in this paper: NCAM, neural cell adhesion molecule; 
PCR, polymerase chain reaction. 
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met et al.,  1982;  Rutishauser et al.,  1983).  The deduced 
polypeptide sequence indicates NCAM is a member of the 
immunoglobulin gene superfamily which also  contains a 
number of other cell-cell adhesion molecules (Rutishauser 
and Jessell, 1988; Williams and Barclay, 1988). The impor- 
tance of NCAM to the neural phenotype is suggested by the 
observation that it is one of the first genes expressed after in- 
duction of the neural phenotype (Kinter, 1987). In Xenopus, 
NCAM transcripts can be detected 2 h after neural induction 
of the ectoderm by the dorsal lip.  Alternative splicing of 
large RNA segments results in four major size classes of 
NCAM polypeptides, 180, 140, 120, and 105 kD (Barbas et 
al.,  1988;  Santoni et al.,  1989;  Gower et al.,  1988).  The 
abundances of these forms vary during development in part 
due to cell type-specific expression and also other factors 
(Small et al., 1987; Chuong and Edelman, 1984). The three 
largest polypeptide forms are  cell surface membrane as- 
sociated and capable of mediating cell-cell adhesion through 
their common amino terminal extracellular domains (Rou- 
gon and Marshak, 1986).  The extent of differences in bio- 
logic functions among these NCAM forms is unknown al- 
though it is attractive to speculate that the two largest forms 
which have transmembrane segments and cytoplasmic do- 
mains could be involved in intracellular signaling (Schuch et 
al.,  1989). 
In addition to alternative splicing which results in readily 
detectable polypeptide size differences, splicing that alters 
shorter segments of the NCAM polypeptide chains has been 
identified (Dickson et al.,  1987; Thompson et al.,  1989; 
Small et al.,  1988;  Santoni et al.,  1989;  Prediger et al., 
1989). Between previously identified exons 12 and 13 (Owens 
et al.,  1987),  several new small exons have been recently 
identified. These are expressed in a significant proportion of 
muscle NCAM mRNAs but some combinations of them also 
appear in brain NCAM mRNAs (Walsh and Dickson, 1989; 
Prediger et al.,  1989).  NCAM and other neural and non- 
neural adhesion molecules have immunoglobulin-like do- 
mains whose primary sequences are somewhat distinct from 
those of true immunoglobulin variable and constant domain 
regions. These domains have been termed C2 (Williams and 
Barclay, 1988) or H (Hunkapiller and Hood, 1989) domains 
to indicate this difference. Although NCAM C2/H domains 
are somewhat distinct, they still have many features consis- 
tent with the basic tertiary structure of an immunoglobulin 
domain: a compact group of antiparallel beta-pleated sheets 
linked by a conserved disulfide bond and adjacent trypto- 
phan which form a "pin" structure (Lesk and Chothia, 1982; 
Edmundson et al., 1975). True immunoglobulin variable do- 
mains differ from constant domains in several features, most 
notably the presence of two extra beta-pleated sheets (named 
C' and C'~ which form the surface of one edge of the domain 
and comprise a portion of the hypervariable region involved 
in antigen binding. We have previously identified within the 
fourth immunoglobulin-like loop of NCAM an amino acid 
sequence encoded by a 30-bp alternative exon (Small et al., 
1988).  The position of this 10 amino acid insertion within 
the fourth NCAM Ig-like loop is coincident with the position 
of amino acids which make up hypervariable regions of true 
immunoglobulin polypeptides. Thus, the inclusion of this 
10 amino acid insert changes the predicted structure of the 
fourth NCAM loop to one somewhat more similar to an Ig- 
like variable domain. In the absence of structural data it is 
not known if these 10 amino acids form a beta-pleated sheet, 
an extra loop on the surface of the fourth domain, or another 
configuration.  However,  as  similar  sequence  alterations 
affect the  structure  and  function of immunoglobulin do- 
mains, this alternative exon could substantially alter the abil- 
ity of NCAM to mediate adhesion during development. For 
convenience we propose the provisional name VASE for this 
exon to signify its properties of mimicking the formation of 
a  domain more like an immunoglobulin variable domain, 
and being an alternatively spliced exon. This acronym has 
the advantage of both convenience and translatability into 
German. 
The identification of the VASE exon in Ig-like loop 4 raises 
the  question  of whether  additional alternative exons  are 
found at this position. Some neurons in primary cultures ex- 
press VASE, while others do not, raising the additional ques- 
tion of what cells and nervous system regions express VASE 
in vivo.  Here we describe the use of the polymerase chain 
reaction (PCR; Saiki et al., 1988) to test RNA populations 
both for additional alternative NCAM exons and also for 
differential VASE expression during development and in dis- 
tinct nervous system regions. 
Materials and Methods 
Tissues and Cell Lines 
All  rat  tissues were taken  from  Sprague-Dawley rats  (Harlan  Sprague 
Dawley,  Inc., Indianapolis, IN).  For embryonic tissues the day after the 
night the animals were mated is defined as day 0. Sources of neural and mus- 
cle cell lines have been previously described (Williams et al., 1985).  Liver 
cell lines H4TG and H411E were obtained from the American Type Culture 
Collection (Rockville, MD). 
RNA Extraction and cDNA Production 
Total cellular RNA was purified from dissected rat tissues and cultured cell 
lines by the guanidine isothiocyanate-CsCl method (adapted from Maniatis 
et al., 1982). The total RNA was then used as a template for specific NCAM 
first strand cDNA synthesis using the 30 base oligonucleotide 1%2: 5'- 
AGGACACACGAGCATGCCTGCGTACCACCA-3'.  This oligonucleotide is 
complementary to the protein coding strand of the rat NCAM cDNA pR18 
(bases 1,317-1,346 of Small et al., 1987) except for a single base mismatch: 
at base 17 the complementary base G is replaced by a C to create an Sph 
I restriction site (see Fig.  1).  This oligo hybridizes to NCAM RNA just 
downstream of the splice junction between exons 7 and 8. In most cases, 
30 ~g of total cellular RNA was used in the first strand cDNA synthesis 
reaction, but in several cases where tissue mass was limiting, significantly 
less RNA was used. As little as 0.5/~g of RNA was sufficient to give a de- 
tectable product after PCR amplification of the first strand cDNA. The 
cDNA synthesis reactions were performed with minor modifications of a 
published method (Geliebter et al., 1986).  Briefly, the RNA was coprecipi- 
tared with 10 ng of the 30mer 17.2, dried down, and dissolved in 10/zl of 
annealing buffer (250 mM KCI, 10 mM Tris, pH 8.3, at 50°C). The mixture 
was then denatured at 80°C for 3' and allowed to anneal for 90' at 55°C. 
Then 16.5 ~1 of reverse transcriptase mix (24 mM Tris 8.3 at 50°C, 16 mM 
MgC12 8 mM DTT,  2 mM each dNTP, 20 U AMV reverse transcriptase; 
Life Sciences Inc., St. Petersburg, FL) was added to each annealing reac- 
tion, and incubated at 50°C for 45'.  I-4 ~,1 of this reaction mix was then 
used directly as a template for amplification by the PCR. 
PCR 
Two basic protocols were used: "cold" and "hot" (radioactive) PCRs. Oligo 
17.2 (see above) and oligo 17.1: 5'-ACC'I~CAGAACGTCCACCCGAAA- 
CATCA-3', were used as primers for PCR amplification in both protocols. 
Oligo 17.1 contains 28 bases of rat NCAM pRl8 cDNA coding sequence 
(bases 1,229-1,256  of Small et al., 1987) except for a single mismatch: at 
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AlaSerT  rpThrArgP  roGluLysGlnGlu 
GCATCGT  GGAC TCGACCAGAGAAGCAAGAG 
Exon 7  ~  ~  Exon 8 




..... C  .....................  >  <  ............  G  .................... 
oligo  17.1  oligo  17.2 
Figure 1.  VASE Position within NCAM. The position of VASE between exons 7 and 8 which comprise the fourth immunoglobulin-like 
domain of NCAM is shown. Oligo nucleotide 17.1 is identical to the cDNA sequence shown except at the position noted. Oligonucleotide 
17.2 is complementary to the cDNA sequence shown except at the position noted. 
base 6 of the oligo the coding strand G  is replaced by a C  creating a Pst 
I restriction site. This sequence lies just 5' of the splice site between exons 
7 and 8 (Fig. 1). 
Cold PCRs were carded out on various cDNA templates under the fol- 
lowing conditions in 25-100/zl volume: 50 mM KCI, 10 mM Tris, pH 8.0, 
0.01% gelatin, 0.2 mM each dNTP, 1.5 mM MgCI2, 3 mg/ml each primer 
and 20 U/ml Taq I polymerase (Cetus Corp., Emeryville, CA). The reac- 
tions were subjected to an initial cycle of 3' at 93°C, 1' at 550C, and 2' at 
72°C, followed  by 29 cycles of r at 92°C, 1' at 55°C, and 2' at 72°C. The 
last 720C step was extended for 8' to maximize full extension of the final 
product. Using these conditions ml /zg of double-stranded fragment was 
routinely produced in a 100-/~1  reaction. 10-td aliquots were directly loaded 
on 6% nondenaturing polyacrylarnide gels and visualized by poststaining 
for 30' with 0.75/~g/ml ethidium bromide. 
Hot reactions (10/zl final volume) were performed under exactly the 
same conditions described above except  that only 1 ng of 32P 5' end-labeled 
primer (oligo 17.1) was used with an excess of the other primer (oligo 17.2), 
which was  unlabeled. We found that a  25:1 excess of unlabeled 17.2 
Figure 2. Developmental expression of VASE in brain. RNA sam- 
pies and  cDNAs  were  prepared from  the indicated tissues and 
"cold" PCRs performed (Materials and Methods). The tissue sam- 
pies were taken from whole brain of the indicated embryonic (E) 
or postnatal (P) age or adult animal. The product of ~250 bases 
is indicated with an arrow. This experiment was repeated four times 
with similar results. The top of the gel is to the right in Figs. 2, 
3, 5, 6,  and 7. 
primer/labeled 17.1 primer gave the best results. After the reaction was com- 
plete,  40  /~l  of loading  dye  (95%  formamide,  0.Sx  TBE,  0.5  mg/ml 
bromophenol blue,  1  mg/ml xylene cyanol) was added to  the reaction, 
which was boiled for 3' and then transferred immediately to an ice bath. 
1-3/~l of  each reaction was then loaded onto a 6% urea-containing sequenc- 
ing gel. The gel was run at 1,200 V, dried, and exposed to film for 3-12 h. 
Results 
The PCR was chosen to test for the presence of alternatively 
spliced exons in the immunoglobulin-like loop 4  region due 
to both its sensitivity and its ability to detect multiple prod- 
ucts  in  a  single  reaction.  Classical  Northern  analysis  or 
nuclease S1 protection assays can sensitively analyze expres- 
sion but do not lead directly to isolation and cloning of new 
sequences. Standard cDNA library production methods can 
be used to clone and sequence new DNA products but are 
very laborious. Thus, the PCR combines both sensitivity and 
efficiency in detection and identification of new DNA prod- 
ucts.  The  complementary oligonucleotides used  for PCRs 
give 118-bp products on NCAM cDNAs containing the VASE 
exon  and  88-bp  products  on  NCAM  cDNAs  lacking  the 
VASE exon (Fig.  1). 
In the first test for additional Ig-like loop 4  exons,  PCR 
products  from  a  variety of brain  ages  were  examined  on 
nondenaturing  gels.  Three  products  were  observed corre- 
sponding to 88,  118, and ~250 bases (Fig. 2). The 118 base 
product steadily increased in abundance during perinatal de- 
velopment in these PCR reactions consistent with the previ- 
ously described appearance of the VASE exon using RNA 
hybridization methods  (Small et al.,  1989).  The 250  base 
product represented a  candidate alternative exon.  However, 
we noted that its developmental appearance and abundance 
seemed to be directly proportional to the abundance of the 
118 base product. To test the identity of the 250 base prod- 
uct, individual bands were cut out, melted, rerun, and also 
tested for single-stranded character with mung bean nucle- 
ase. These experiments indicated the 250 base product was 
a  heteroduplex between the  118  and 88 base strands which 
migrates  anomalously  on  nondenaturing  gels,  presumably 
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VASE expression during brain 
development.  RNA  samples 
and  cDNAs  were  prepared 
from the indicated tissues and 
"hot"  PCRs  were  performed 
and  run  on denaturing  gels. 
Samples  R5.6 and  R8.2 are 
mouse L cell lines transfected 
with 140 kD rat NCAM con- 
taining and lacking the VASE 
exon,  respectively.  The  118- 
bp product  is denoted  by the 
arrow in the R5.6 lane and the 
88-bp product  is  denoted  by 
the  arrow  in the  R8.2 lanes. 
Each of these lanes also con- 
tains  a  faster  migrating  ar- 
tifactual  band.  These  bands 
appear to be due to partial hybridization of the PCR oligonucleo- 
tide(s) with the extension product based on the following evidence: 
(a) their abundance is decreased by increasing the formamide con- 
centration of the sample buffer used to load the gel; and (b) their 
abundance diminishes when the ratio of unlabeled to labeled oligo- 
nucleotide  in the  PCR is decreased.  Unfortunately,  in order to 
achieve a significant yield of labeled PCR product from the small 
amounts of RNA and cDNA available from some samples, we were 
forced to use a higher ratio of unlabeled to labeled oligonucleotide 
in order to drive the reaction. Other samples are whole brain from 
embryonic  day  15  (E/5),  the  indicated  postnatal  (P)  day, adult 
brain,  adult liver, and a control to which no RNA was added.  A 
very weak band is observed here with adult liver. Kinetic analysis 
of the appearance of the PCR products suggests that the abundance 
of NCAM RNA in liver is -~l,000-fold less than that in brain (data 
not shown). This experiment was performed at least twice with in- 
dependent preparations  of all samples. 
due to its partial single-stranded character (data not shown, 
Small, S. J., and R. Akeson, manuscript in preparation). As 
an additional  test of the identity of the products obtained, 
PCRs were performed with 32-P-labeled oligonucleotide and 
analyzed on urea containing  denaturing  gels.  As controls, 
fibroblasts transfected with cDNAs for a single NCAM iso- 
form were included.  These experiments demonstrated  118 
base products (Fig.  3,  right arrow) using the recombinant 
cell line R5.6, which expresses 140 kD NCAM+VASE, and 
88 base products (Fig.  3, left arrow) with the recombinant 
cell line R8.2, which expresses 140 kD NCAM-VASE. The 
additional minor bands seen in these lanes are mobility ar- 
tifacts of the major bands (Fig. 3 legend). Only products of 
these same sizes,  88  and  118  bases, were seen with brain 
samples from all the  ages tested,  suggesting that no addi- 
tional alternative exons are found in brain.  To confirm the 
identity of these samples,  PCR products from adult brain 
were sequenced and found to be identical to the previously 
reported rat NCAM sequence (data not shown). The perina- 
tal developmental appearance of the VASE exon which was 
previously observed by Northern analysis (Small et al., 1988) 
is reproduced almost exactly by the PCR products, indicat- 
ing that the PCR can be used to quantitatively estimate the 
relative proportion of NCAM RNAs with and without VASE 
in a  tissue. 
These  combined  experiments  indicate  that  within  the 
limits of sensitivity of the methods, if any additional alterna- 
Figure 4. Taq I Digestion of PCR products. "Cold" PCR reactions 
were performed with cDNAs from the cell lines and brain regions 
indicated below. Half  of  each reaction was digested with the restric- 
tion enzyme Taq I, the samples were run in adjacent lanes on a non- 
denaturing gel, and visualized by staining with ethidium bromide. 
The control sample in lane A is from recombinant R5.6 cells which 
express only 140 kD NCAM+ VASE. Total digestion of the upper 
ll8-bp band to two smaller products is seen. In the other samples 
the ll8-bp band is also digested to completion but the 88-bp band 
(from NCAM-VASE) is not digested as predicted. The samples are 
A, R5.6 ceils; B, El5 heart;  C, PI brain; D, P4 brain; E, P7 brain; 
F, P12 brain; G, adult brain; H, cerebellum; 1, cerebrum; J, olfac- 
tory bulb; K, thalamus; L, olfactory tubercule; M, basal Ganglia; 
N, Midbrain;  O, brain stem; P, adult heart.  All brain regions were 
dissected  from adult rats.  This experiment  was performed  twice 
with similar results. 
tive exons between exons 7 and 8 exist, they must be 30 bp 
in size. As an initial test of the existence of such additional 
30-bp alternative exons,  PCR products were digested with 
Taq I a restriction enzyme which cuts within the VASE se- 
quence  but  not  elsewhere  within  the  amplified sequence. 
When PCR-amplified products produced from cDNAs from 
rat brain ages embryonic day 11 through adult were cut with 
Taq I, complete digestion was observed in all cases (Fig. 4). 
Thus, there is no evidence for alternative exon(s) which do 
not have a Taq I  site. 
The Taq I digestion experiment indicates that all alterna- 
tive exons at the 7/8 junction must be 30 bp in length and 
must contain a Taq I site. To determine whether any alterna- 
tive exons  in  addition  to the one previously observed are 
present in the rat, the 118-base PCR product was labeled and 
used to probe genomic clones spanning the entire region be- 
tween exons 7 and 8. This probe should hybridize to both the 
previously identified exon and also any possible additional 
exons amplified by PCR. In Southern blot experiments a sin- 
gle 1,285-bp Ava 1-Hind HI genomic fragment hybridized to 
this probe. Thus, any alternative exons must be within this 
fragment. This genomic fragment was completely sequenced. 
Five Taq I sites were found (data not shown). The only Taq 
I  site that was properly positioned within a  30-bp segment 
surrounded by the consensus splice donor and acceptor se- 
quences was contained within the previously identified alter- 
native VASE exon. Thus, within the limits of sensitivity of 
the methods employed, VASE is the only alternative exon at 
the 7/8 junction expressed in rat brain throughout develop- 
ment. 
In these experiments it is possible that additional  exons 
present at the 7/8 junction were not detected due to their low 
abundance.  Exons that represent a  minor portion of total 
brain NCAM RNA could be expressed by cells with an ana- 
tomically  restricted  distribution  and  represent  a  major 
proportion of the NCAM RNA of these cells. To test this pos- 
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tinct  adult  brain  regions.  RNA 
preparations  from the  indicated 
adult nervous system  regions were 
prepared  and  PCRs performed 
as in Fig. 3. BG,  basal ganglia; 
B-stem,  brainstem;  Cbell,  cere- 
bellum:  cortex,  cerebral  cortex; 
Hipp,  hippocampus;  Mid,  mid- 
brain; Thai, thalamus; OB, olfac- 
tory bulb;  OF., olfactory epithe- 
lium; LO~, lateral olfactory tract; 
DRG,  dorsal  root  ganglia; Adr, 
adrenal;  Heart,  adult heart.  Re- 
sults from a representative exper- 
iment are shown. All regions were 
analyzed at least twice using in- 
dependent dissections and RNA 
preparations. 
sibility, adult rat brain was dissected into discrete regions. 
RNA preparations from these regions were tested using the 
PCR methodology. In addition two components of the pe- 
ripheral  nervous system (PNS),  adrenal gland and  dorsal 
root ganglia, and also adult heart were examined. All central 
nervous system (CNS) and PNS regions contained signifi- 
cant amounts of NCAM lacking any 7/8 exon as indicated by 
the presence of the 88 base PCR product (Fig.  5,  left ar- 
row). The VASE exon was also observed (right arrow) but 
no additional size classes of alternative exons were seen in 
these experiments. Thus, there is no support for the hypothe- 
sis  of anatomically restricted expression of additional 7/8 
exons. However, examination of the ratios of the upper band 
(with  VASE)  to  the  lower band  in  these experiments did 
reveal  significant region-specific regulation of splicing  of 
VASE.  Most  CNS  regions  expressed mixtures of NCAM 
with and without VASE.  Some CNS  regions, particularly 
olfactory bulb  and  spinal  cord,  predominantly expressed 
NCAM  without VASE.  The VASE  exon could not be de- 
tected at all in the olfactory epithelium sample. The PNS tis- 
sues had much lower (dorsal root ganglia) or undetectable 
(adrenal) levels of VASE.  Overall VASE expression in the 
PNS was generally less than that in the CNS.  In film ex- 
posures 20 times longer than those shown, VASE expression 
could be detected at low levels in all the tissues examined 
with the lowest levels observed in olfactory epithelium fol- 
lowed  by  adrenal.  Assuming  linearity  of film  response, 
NCAM RNAs in these tissues are ~99.9% VASE negative. 
These combined results demonstrate that alternative splicing 
at  the  7/8 junction  is  independently regulated  in  distinct 
regions of the nervous system. 
As a further test of alternative NCAM splicing at the exon 
7/8 junction, nonneural tissue from embryonic day 15 (El5) 
whole  embryos and  also  El5  rat  brain,  body,  and  heart 
cDNA samples were examined. Heart was the muscle tissue 
chosen for emphasis because it can be relatively cleanly dis- 
sected free of neural or glial elements. It is very difficult to 
obtain samples of skeletal muscle which are free of  these ele- 
Figure 6.  VASE expression in the rat embryo. RNA preparations 
from embryonic day 15 (E/5) whole embryos or the regions indi- 
cated were prepared and PCRs performed. Adult heart is shown for 
comparison with the 118- and 88-bp PCR products denoted by the 
right and left arrows, respectively. 
ments,  particularly  the  Schwann  cells  of  the  ingrowing 
nerves. At El5, very little VASE is observed in whole em- 
bryo, body, or brain (Fig. 6, the ll8-base band is the right 
arrow)  but the  embryonic heart  sample  shows  significant 
VASE levels. These results with brain samples are consistent 
with those obtained using the unlabeled PCR reaction (Fig. 
2). It is interesting to note that when the whole body sample 
(including heart) from an El5 rat is assayed, little VASE is 
observed indicating the effects of RNA dilution on the PCR 
assay. VASE could be detected in these El5 body samples in 
longer film exposures which grossly overexposed the 88 base 
band. Adult heart has large amounts of NCAM with VASE. 
Again, no additional exons were observed in these nonneurai 
tissues at the exon 7/8 junction. These experiments do illus- 
trate that NCAM splicing at the 7/8 junction is independently 
regulated in different tissues during development. 
The experiments testing NCAM splicing in nervous sys- 
tem regions and embryos are limited by the fact that each of 
these samples contains multiple cell types. As a final test for 
the presence of additional 7/8 exons, individual cell types 
were tested with the PCR. By using clonal cell lines in cul- 
ture, cells of  known phenotype could be examined. The mus- 
cle cell line L6; the pheochromocytoma cell line PC12 and 
additional neuronal lines B35 and B104;  the Schwannoma 
cell line RN22 and the additional glial cell lines C6 and B12; 
and also the control liver cell lines H4TG and H411E and 
control fibroblast L cells were examined. In all cases, no ad- 
ditional size classes of 7/8 exon were detected (Fig. 7). The 
positive control 118 and 88-base bands are denoted by the 
arrows in the lanes for recombinant cell lines R5.6 and R8.2, 
respectively. No NCAM expression was detected in the he- 
patocyte or fibroblast lines. All the neural and muscle cells 
expressed very little VASE.  The regulation of splicing of 
VASE was also examined using two model systems for cell 
differentiation in vitro: the fusion of L6 myoblasts to form 
myotubes and the morphologic differentiation of PC12 cells 
after nerve growth factor treatment.  Myoblast fusion does 
not increase the abundance of the 30-bp exon in L6 cells 
(lanes L6 vs L6-fused). Similar results were found with the 
muscle cell line H9c2 (data not shown). PC12 cells do ex- 
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cells grown in culture were prepared and PCRs performed as in Fig. 
3. L6 myoblasts were induced to fuse to form myotubes by growing 
myoblasts to high density in DME with 10% serum and then reduc- 
ing the serum concentration to 2.5%  for 6 d. Fusion was visually 
estimated at 40-50% at the time of cell harvest.  PCI2 cells were 
treated  with  nerve  growth  factor  (Collaborative  Research,  20 
ng/ml) for 8 d before harvest. 
press low levels of VASE under normal culture conditions 
but this amount does not increase in relative abundance after 
NGF  treatment  (arrow,  lane  PC12+NGF).  In  summary, 
these experiments also did not detect additional exons at the 
7/8 junction, and further indicated that splicing at this junc- 
tion is not regulated by mechanisms which play a role in two 
cell culture model systems. 
Discussion 
Using all four of the strategies for testing different tissues, 
cell types, and stages of development, no exon other than the 
previously described VASE was identified at the exon 7/8 
junction in rat. The quantitative limits on this statement that 
no additional exons can be found can be estimated from data 
within the experiments. By overexposing films we are readily 
able to detect  ll8-base bands at abundances that are 1.0% 
of the 88-base bands. For example, the llS-base band is not 
readily detected in samples of whole embryonic day 15 rats 
but can be easily detected in samples of El5 heart. However, 
on exposures 5-20 times those shown, the ll8-base band is 
present in the whole embryo samples as would be expected. 
Thus, these results indicate both that the PCR technique is 
extremely useful for examining developmental regulation of 
alternative  splicing  and  also  that  its  extreme  sensitivity 
necessitates  careful  analysis  of the  reproducibility  of the 
products obtained. We conclude that additional exons at the 
7/8 junction,  if any, must be expressed at abundances at or 
below the 1.0 % level, in cell types that represent minor popu- 
lations within the tissues examined, or in specialized tissues 
or cell types not examined here. 
This conclusion highlights a striking contrast between two 
regions of alternative splicing in NCAM. The genomic orga- 
nization of NCAM as described in the chicken (Owens et al., 
1987) and confirmed by our laboratory in the rat (Chen et 
al.,  1990  and Reyes, A.  A.,  and R.  Akeson,  unpublished 
data) is a 5' small cluster of seven exons contained in ",~8 kb 
of genomic sequence which encode the first three and one 
half immunoglobulin-like domains. These are followed by a 
10.5-kb segment which contains only the VASE exon. This 
is followed by exons 8-12 which are clustered in •6  kb and 
then another large gap of 15 kb between exons  12 and  13. 
Exons 12 and 13 encode a fibronectin-like region of NCAM. 
Recently, this latter large gap has been shown to contain sev- 
eral small alternatively spliced exons (Santoni et al.,  1987; 
Barbas et al.,  1988; Prediger et al.,  1989).  This result is in 
contrast  to  our  finding  of a  single  exon  in  the  10.5-kb 
genomic gap between exons 7  and 8. 
All five NCAM Ig-like domains are each encoded by two 
exons  consistent  with  the  proposal  of a  primordial  half- 
domain-encoding exon giving rise to the immunoglobulin 
supergene family (Bourgois,  1975;  Hunkapiller and Hood, 
1989).  No alternatively spliced exons have been detected in 
NCAM between Ig-like domains within domains other than 
domain 4. The position of the VASE exon within an Ig-like 
domain as determined by this genomic organization is coin- 
cident with the major position of difference between true im- 
munoglobulin constant and  variable domains.  Further  ex- 
periments are clearly necessary to determine the nature of 
the  NCAM  structural  and  functional  changes  caused  by 
VASE exon insertion.  Thus, the acronym VASE is intended 
provisionally and should not be taken to indicate that the true 
structure of the VASE containing fourth NCAM domain is 
identical to that of a true immunoglobulin variable domain. 
NCAM has homology to a number of other neural adhesion 
molecules including L1, TAG-l, contactin, and DCC (Moos 
et al.,  1988;  Furley et al.,  1990;  Ranscht  1988;  Fearon et 
al.,  1990). It will be interesting to determine if the domains 
of these molecules are also encoded by split exons and also 
whether they exhibit alternative splicing within the domains. 
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VASE exon, we had previously demonstrated that individual 
neuronal cells in culture independently regulated expression 
of  VASE; some cells had readily detectable VASE expression 
while others did not. The results obtained here with the PCR 
technique extend the observation that this splicing event is 
independently regulated in different cells by demonstrating 
that distinct brain regions show clear differential regulation 
of VASE expression. A portion of this regulation correlates 
with embryologic origins of the tissues tested. Both of the 
neural crest-derived elements which contribute to the pe- 
ripheral nervous system, adrenal gland and dorsal root gan- 
glia, showed low levels of VASE expression. The olfactory 
epithelium, which is derived from the olfactory placode, had 
essentially no VASE expression. In contrast, CNS regions 
which are derived from the neural tube, although varying in 
expression from low (olfactory bulb and spinal cord) to high 
(thalamus), all had readily detectable levels of VASE expres- 
sion. Further tests of the correlation between VASE expres- 
sion and embryologic origin would include analyses of addi- 
tional placode and neural crest-derived tissues. 
An alternative hypothesis consistent with much of the data 
presented is that expression of VASE is inversely correlated 
with the degree of synaptic plasticity of a tissue. In the de- 
veloping nervous system, very little VASE is expressed dur- 
ing  early  development when  there  is  significant cellular 
growth and synaptic connections are first being formed and 
are relatively labile. In adult rats in which brain growth has 
ceased and synaptic connections are less labile, higher levels 
of VASE are observed. In adult vertebrates, the olfactory sys- 
tem is unique in that continuous cellular turnover of mature 
neurons occurs in the epithelium which must be accompa- 
nied by continuous synaptic rearrangement within the olfac- 
tory bulb. Both components of this system are also uniquely 
low in their levels of VASE expression. Clearly this hypothe- 
sis is not sufficient to explain all aspects of regulation of 
VASE expression as adrenal, a seemingly static tissue, also 
has low levels of expression. Previous workers have shown 
a rough correlation between periods of synaptic development 
and plasticity and the presence of polysialic acid groups on 
NCAM. These groups are thought to decrease the ability of 
NCAM to mediate cell-cell adhesion (Hoffman and Edel- 
man, 1983;  Rutishauser et al.,  1988).  The relationship be- 
tween VASE content and polysialylation is not known. The 
role  of both  VASE  expression  and polysialylation in  the 
modulation of the strength of NCAM-mediated cell adhesion 
during development requires further analysis. 
How is VASE expression regulated? These results clearly 
indicate that VASE regulation is not stochastic. However, the 
mechanisms which do regulate VASE expression  are  not 
clear. No changes in VASE expression were observed after 
treatment of PC12 cells with NGE Likewise, L6 muscle cell 
fusion to form myotubes was not accompanied by VASE ex- 
pression even though significant alterations in NCAM splic- 
ing at the exon 12/exon 13 junction were observed during this 
change (Reyes, A. A., S. J. Small, and R. Akeson, unpub- 
lished data). The experiments described here do eliminate 
the hypothesis that a simple biological clock such as a sys- 
temic hormonal factor induces the simultaneous develop- 
mental appearance of VASE expression in all cells of all tis- 
sues.  Such a  simple clock cannot regulate VASE splicing 
because this exon appears earlier in heart than in the nervous 
system and some neural regions such as the olfactory epithe- 
lium do not express significant VASE at any time. However, 
a biologic clock in the form of a circulating factor could still 
regulate expression if it is further proposed that some ceils 
(such as cardiac tissue) develop receptor for the factor ear- 
lier than others and some cells (such as olfactory epithelium) 
never express the receptor. Thus, there could still be a sys- 
temic component involved in regulation of VASE expression. 
The results described here indicate individual brain regions 
vary dramatically in VASE expression. The previous studies 
with antibody to the VASE-encoded peptide demonstrated 
that individual neurons in embryonic rat brain primary cul- 
tures regulated VASE expression independently. These com- 
bined results suggest that regulation of VASE expression oc- 
curs at the level of single cells. Thus, the simplest hypothesis 
consistent with all these data is that regulation of VASE ex- 
pression is cell intrinsic. Regardless of the nature of regula- 
tion of VASE splicing and other splicing events that deter- 
mine which NCAM forms are expressed, these results do 
emphasize that future studies of NCAM functions during de- 
velopment must consider the precise alternatively spliced 
form of NCAM being expressed. Conclusions based on re- 
agents that identify most or all NCAM forms may not be ap- 
propriate to the potentially diverse biologic capabilities of 
the increasingly large number of individual distinct NCAM 
forms. 
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